# Po-han Chen

> Po-han Chen is a pre-seed investor backing Medical and Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: Angel Investor
- Total investments: 1
- Last investment: Dec 2018
- Lead investor: 100%
- Last updated: Sep 2026

Po-han Chen is a pre-seed investor focused on Medical and Health Care.

## Contacts

5 contacts available for Po-han Chen: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/po-han-chen-b3e8?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Artificial Intelligence | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cancerfree Biotech | CancerFree Biotech's platform E.V.A. (Ex Vivo Avatar) uses a proprietary culture system and AI image recognition to expand circulating tumor cells from just 20 mL of blood into 3D tumor organoids. These organoids drive personalized treatment by facilitating drug sensitivity testing and identifying the most effective drugs for each patient. Bytesting therapies directly on patient-derived cells and conducting proprietary organoid analysis, E.V.A. generates personalized screening reports tailored to each patient's unique tumor profile. E.V.A. also supports pharmaceutical companies by validating drug efficacy on patient-derived cells and identifying the most promising candidates for clinical trials. The organoid screening data offers early insights into drug efficacy, reducing the risk of late-stage trial failure and helping to select the best-in-class therapies. Additionally, as a more physiologically relevant model, E.V.A. eliminates the need for traditional cell line and animal testing, producing more accurate and clinically predictive data. | $553.6K | Pre-Seed | Dec 01, 2018 | https://www.cancerfree.io/ |

1 of 1 investments shown.

## Co-investors
- [UNIMED HEALTHCARE](https://shizune.co/investors/profile/unimed-healthcare-inc) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund

### Similar country
- [National Development Fund of Taiwan Government](https://shizune.co/investors/profile/national-development-fund-of-taiwan-government) — VC Fund
- [Darwin Venture Management](https://shizune.co/investors/profile/darwin-venture-management) — VC Fund
- [AVA Angels](https://shizune.co/investors/profile/ava-angels) — VC Fund

## Featured in investor lists
- [Medical Investors in Taiwan](https://shizune.co/investors/medical-investors-taiwan)
- [Biotechnology Investors in Taiwan](https://shizune.co/investors/biotechnology-investors-taiwan)
- [Biotech Investors in Taiwan](https://shizune.co/investors/biotech-investors-taiwan)

## FAQ

### What does Po-han Chen invest in?

Po-han Chen invests primarily in Medical, Health Care and Biotechnology startups, most often at Pre-Seed stage. Most of the 1 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Po-han Chen?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Po-han Chen last invest?

The most recent investment recorded for Po-han Chen closed in Dec 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co